The metabolism of Ropinirole can be decreased when combined with Isradipine. Secobarbital may increase the sedative activities of Ropinirole. Lidocaine may increase the sedative activities of Ropinirole. 7-Nitroindazole may increase the sedative activities of Ropinirole. Ropinirole may increase the atrioventricular blocking (AV block) activities of Befunolol. Zonisamide may increase the sedative activities of Ropinirole. Fentanyl may increase the sedative activities of Ropinirole. The serum concentration of Nebivolol can be increased when it is combined with Ropinirole. The metabolism of Flutamide can be decreased when combined with Ropinirole. Opium may increase the sedative activities of Ropinirole. Ropinirole may increase the atrioventricular blocking (AV block) activities of Practolol. The therapeutic efficacy of Iobenguane can be decreased when used in combination with Ropinirole. Levetiracetam may increase the sedative activities of Ropinirole. The metabolism of Halofantrine can be decreased when combined with Ropinirole. Chlorphenamine may increase the sedative activities of Ropinirole. Alfaxalone may increase the sedative activities of Ropinirole. The metabolism of Ropinirole can be decreased when combined with Midostaurin. The metabolism of Ergotamine can be decreased when combined with Ropinirole. The risk or severity of adverse effects can be increased when Nitrendipine is combined with Ropinirole. Ropinirole may increase the atrioventricular blocking (AV block) activities of Platelet Activating Factor. Clomipramine may increase the sedative activities of Ropinirole. The metabolism of Ropinirole can be decreased when combined with Clarithromycin. The serum concentration of Ropinirole can be decreased when it is combined with Dabrafenib. The serum concentration of Ropinirole can be increased when it is combined with Vemurafenib. Zopiclone may increase the sedative activities of Ropinirole. Butorphanol may increase the sedative activities of Ropinirole. The serum concentration of Ropinirole can be increased when it is combined with Osimertinib. Trazodone may increase the sedative activities of Ropinirole. Butabarbital may increase the sedative activities of Ropinirole. Perospirone may increase the sedative activities of Ropinirole. Alfentanil may increase the sedative activities of Ropinirole. The metabolism of Debrisoquin can be decreased when combined with Ropinirole. Methylecgonine may increase the sedative activities of Ropinirole. The metabolism of Eltrombopag can be decreased when combined with Ropinirole. Paliperidone may increase the sedative activities of Ropinirole. The serum concentration of Ropinirole can be increased when it is combined with Ciprofloxacin. Allopregnanolone may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Lacidipine is combined with Ropinirole. The metabolism of Tamsulosin can be decreased when combined with Ropinirole. The metabolism of Donepezil can be decreased when combined with Ropinirole. Chloroprocaine may increase the sedative activities of Ropinirole. The metabolism of Ropinirole can be decreased when combined with Voriconazole. The metabolism of Ropinirole can be increased when combined with Lumacaftor. The risk or severity of adverse effects can be increased when Ropinirole is combined with Enalapril. Asenapine may increase the sedative activities of Ropinirole. The therapeutic efficacy of Ropinirole can be decreased when used in combination with Cariprazine. Fludiazepam may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Canagliflozin. The metabolism of Ropinirole can be decreased when combined with Brofaromine. The metabolism of Aminophenazone can be decreased when combined with Ropinirole. Clonazepam may increase the sedative activities of Ropinirole. The metabolism of Ropinirole can be decreased when combined with Atazanavir. Glutethimide may increase the sedative activities of Ropinirole. The metabolism of Ropinirole can be decreased when combined with Procarbazine. The metabolism of Valbenazine can be decreased when combined with Ropinirole. The metabolism of Ropinirole can be decreased when combined with Boceprevir. Ropinirole may increase the atrioventricular blocking (AV block) activities of Arotinolol. Ropivacaine may increase the sedative activities of Ropinirole. The metabolism of Cephalexin can be decreased when combined with Ropinirole. The metabolism of Ropinirole can be decreased when combined with Pargyline. The metabolism of Anagrelide can be decreased when combined with Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Metolazone. Morphine may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Hydralazine. The metabolism of Ropinirole can be decreased when combined with Nelfinavir. The metabolism of Ritonavir can be decreased when combined with Ropinirole. Articaine may increase the sedative activities of Ropinirole. The metabolism of Ropinirole can be decreased when combined with Clotrimazole. Ropinirole may increase the atrioventricular blocking (AV block) activities of Alprenolol. The metabolism of Ropinirole can be decreased when combined with Caffeine. The risk or severity of adverse effects can be increased when Ropinirole is combined with Chlorthalidone. The serum concentration of Ropinirole can be increased when it is combined with Peginterferon alfa-2b. The metabolism of Procainamide can be decreased when combined with Ropinirole. The metabolism of Piperazine can be decreased when combined with Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Irbesartan. The metabolism of Diclofenac can be decreased when combined with Ropinirole. The metabolism of Acetylcholine can be decreased when combined with Ropinirole. Dosulepin may decrease the antihypertensive activities of Ropinirole. Levocabastine may increase the sedative activities of Ropinirole. The metabolism of Oxtriphylline can be decreased when combined with Ropinirole. Quetiapine may increase the sedative activities of Ropinirole. Methadyl Acetate may increase the sedative activities of Ropinirole. The metabolism of Ixazomib can be decreased when combined with Ropinirole. The metabolism of Ropinirole can be decreased when combined with Lovastatin. The metabolism of Nicardipine can be decreased when combined with Ropinirole. Bupivacaine may increase the sedative activities of Ropinirole. Trans-2-Phenylcyclopropylamine may increase the sedative activities of Ropinirole. Agomelatine may increase the sedative activities of Ropinirole. The metabolism of Resveratrol can be decreased when combined with Ropinirole. The metabolism of Vernakalant can be decreased when combined with Ropinirole. The metabolism of Captopril can be decreased when combined with Ropinirole. The serum concentration of Ropinirole can be decreased when it is combined with Enzalutamide. Primidone may increase the sedative activities of Ropinirole. Ketamine may increase the sedative activities of Ropinirole. The metabolism of Carmustine can be decreased when combined with Ropinirole. The metabolism of Dexmethylphenidate can be decreased when combined with Ropinirole. Bromazepam may increase the sedative activities of Ropinirole. Clemastine may increase the sedative activities of Ropinirole. Etifoxine may increase the sedative activities of Ropinirole. Dihydrocodeine may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Fosinopril. The risk or severity of adverse effects can be increased when Ropinirole is combined with Furosemide. The serum concentration of Ropinirole can be increased when it is combined with Estrone. The serum concentration of Ropinirole can be increased when it is combined with Fosaprepitant. Difenoxin may increase the sedative activities of Ropinirole. Molindone may increase the sedative activities of Ropinirole. Enflurane may increase the sedative activities of Ropinirole. Amisulpride may increase the sedative activities of Ropinirole. Hydroxyzine may increase the sedative activities of Ropinirole. Osanetant may increase the sedative activities of Ropinirole. Quazepam may increase the sedative activities of Ropinirole. The serum concentration of Ropinirole can be decreased when it is combined with Mitotane. Ropinirole may increase the atrioventricular blocking (AV block) activities of Labetalol. Ropinirole may increase the atrioventricular blocking (AV block) activities of Bufuralol. The metabolism of Benzatropine can be decreased when combined with Ropinirole. Ropinirole may increase the atrioventricular blocking (AV block) activities of Bopindolol. The risk or severity of adverse effects can be increased when Ropinirole is combined with Moexipril. The serum concentration of Ropinirole can be increased when it is combined with Secoisolariciresinol. Piritramide may increase the sedative activities of Ropinirole. Topiramate may increase the sedative activities of Ropinirole. The metabolism of Ranitidine can be decreased when combined with Ropinirole. Desipramine may increase the sedative activities of Ropinirole. The metabolism of Lomustine can be decreased when combined with Ropinirole. Methapyrilene may increase the sedative activities of Ropinirole. The risk or severity of adverse effects can be increased when Ropinirole is combined with Amiloride. Propofol may increase the sedative activities of Ropinirole. Deramciclane may increase the sedative activities of Ropinirole. Oxymorphone may increase the sedative activities of Ropinirole. The metabolism of Omeprazole can be decreased when combined with Ropinirole. The metabolism of Naproxen can be decreased when combined with Ropinirole.